Article Text

New drugs to be assessed for treating animal African trypanosomosis

Statistics from

THREE contracts for the development of new drugs and diagnostic tests for animal African trypanosomosis (AAT) have been awarded by the Global Alliance for Livestock Veterinary Medicines (GALVmed).

In May 2011, the Department for International Development (DfID) awarded the Edinburgh-based charity a 30-month grant of £8 million to help in the development of drugs, diagnostics and potential vaccines for the control of AAT. The disease is estimated to cost Africa US $5 billion annually, GALVmed says, and affects over 10 million km2 fertile land across nearly 40 African countries; approximately 3 …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.